Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
The company operates as a pharmaceutical company.
Hetero Labs Limited, is an unlisted public company incorporated on 10 March, 1989. It is classified as a public limited company and is located in Hyderabad, Telangana. It's authorized share capital is INR 320.00 cr and the total paid-up capital is INR 277.06 cr.
Read more
Buy Dashboard using Credits
This action will use 1 of your credits. Are you sure you want to go ahead?
Credits Balance:
0
** All rupee values in INR crores. Based on March 2023 numbers.
9.92%
21.7%
10.8%
12.37%
0.24%
10.59%
1.54
1.55
0.02
-0.15
1.85
-0.05
Buy Report or Plans
Company dashboard
Five year financials and ratios
Risk analysis
Interactive charts
All financials
All annual returns
MoA and AoA
Latest financials
Latest annual return
MoA and AoA
Five year financials and ratios
Shareholding and group structure
Litigation and more
Everything in financial report
Peers and financials
* GST not included
** Reports & MCA filings will be based on the latest available financials.
India
(41)
| State | Type | Address |
|---|
Locations on Map
Filter (4)
Severe Risk
Moderate Risk
Low Risk
Read more
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Solvency + | |||||
| Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Liquidity + | |||||
| Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Performance | |||||
| Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return + | |||||
| Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Efficiency + | |||||
| Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital | |||||
| Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
IDBI Trusteeship Services Limited
No. of Loans: 1
Total Amount : 5,200.5 cr
State Bank of India
No. of Loans: 4
Total Amount : 700.4 cr
Mahindra and Mahindra Financial Services Limited
No. of Loans: 47
Total Amount : 24.5 cr
HDFC Bank Limited
No. of Loans: 6
Total Amount : 0.8 cr
Union Bank of India
No. of Loans: 3
Total Amount : 0.5 cr
Axis Bank Limited
No. of Loans: 1
Total Amount : 0.2 cr
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Parthasaradhi Reddy Bandi
Shareholder
|
00015899 | 28 years |
| Director | Srinivas Reddy Male | 00016085 | 16 years |
| Whole-time Director | Venkatanarasa Reddy Attunuri | 00023432 | 11 years |
| Whole-time Director | Mohana Reddy Chilukuri | 00208921 | 25 years |
| Director | Rathnakar Reddy Kura | 00211510 | 11 years |
| Managing Director | Bandi Vamsikrishna
Shareholder
|
01014619 | 17 years |
| Director | Vasudevan Sujesh | 08240092 | 1 years |
| Director | Govindaraju Bhavani | 09657046 | 1 years |
| CFO | Bhavesh Bansidhar Pujara | <HIDDEN> | 2 years |
| CS | Sudershan Pallap | <HIDDEN> | 4 years |
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| Camber Pharmaceuticals Inc | United States | - | - |
| Hetero Singapore PTE Ltd | Singapore | - | - |
| Camber Consumer Care Inc | United States | - | - |
| Hetero Australia PTY LTD | Australia | - | - |
| Hetero Labs Nigeria Limited | Nigeria | - | - |
| DMN Invest LLC | Russian Federation | - | - |
| Makiz Pharma LLC | Russian Federation | - | - |
| HETERO WIND POWER (PENNAR) PRIVATE LIMITED | Telangana | 2015 | ₹ 65.0 Cr |
| Hetero FZCO | United Arab Emirates | - | - |
| HETERO MED SOLUTIONS LIMITED | Telangana | 2007 | ₹ 32.2 Cr |
| HETERO WIND POWER LIMITED | Telangana | 2010 | ₹ 154.0 Cr |
| ASPIRO PHARMA LIMITED | Telangana | 2014 | ₹ 254.1 Cr |
| Hetlabs Mexico S.A. DE C.V | Mexico | - | - |
| Akar Columbia SAS | Colombia | - | - |
| Hetero Kenya Limited | Kenya | - | - |
| Hetero Malta Limited | Malta | - | - |
| Excellan Peru SAC | Peru | - | - |
| Camber Pharma Mexico S A De C V. | Mexico | - | - |
| Hetero Philippines Inc. | Philippines | - | - |
| HETERO WIND POWER (ANANTA) PRIVATE LIMITED | Telangana | 2015 | ₹ 25.0 L |
| HETERO WIND POWER (RAYALA) PRIVATE LIMITED | Telangana | 2015 | ₹ 50.0 L |
| Pharmed Healthcare Company SAE | Egypt | - | - |
| Hetero (Thailand) Limited | Thailand | - | - |
| ANNORA PHARMA PRIVATE LIMITED | Telangana | 2015 | ₹ 286.0 Cr |
| WALLET PHARMA PRIVATE LIMITED | Telangana | 2015 | ₹ 98.0 Cr |
| EVARIC PHARMA PRIVATE LIMITED | Telangana | 2015 | ₹ 1.0 L |
| HETERO BIOTECH LIMITED | Telangana | 2004 | ₹ 5.0 L |
The incorporation date of HETERO LABS LIMITED is 10 March, 1989
The authorized share capital of HETERO LABS LIMITED is INR ₹ 320.0 Cr.
The paid-up capital of HETERO LABS LIMITED is INR ₹ 277.1 Cr.
The registered address of HETERO LABS LIMITED is #7-2-A2, Industrial Estate, Sanath Nagar, Sanathnagar I E Balanagar Hyderabad Telangana - 500018
The CIN number of HETERO LABS LIMITED is U24110TG1989PLC009723.
Expand
Delete
Collapse
See
details
